These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 2183635

  • 1. Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression.
    Kocsis JH, Croughan JL, Katz MM, Butler TP, Secunda S, Bowden CL, Davis JM.
    Am J Psychiatry; 1990 May; 147(5):621-4. PubMed ID: 2183635
    [Abstract] [Full Text] [Related]

  • 2. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants.
    Chan CH, Janicak PG, Davis JM, Altman E, Andriukaitis S, Hedeker D.
    J Clin Psychiatry; 1987 May; 48(5):197-200. PubMed ID: 3571174
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK, van den Broek WW, Mulder PG, Moleman P, Bruijn JA.
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [Abstract] [Full Text] [Related]

  • 4. Response of psychotic and nonpsychotic depression to phenelzine.
    Janicak PG, Pandey GN, Davis JM, Boshes R, Bresnahan D, Sharma R.
    Am J Psychiatry; 1988 Jan; 145(1):93-5. PubMed ID: 3337297
    [Abstract] [Full Text] [Related]

  • 5. Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics.
    Magni G, Garreau M, Orofiamma B, Palminteri R.
    Neuropsychobiology; 1989 Jan; 20(3):126-31. PubMed ID: 2668780
    [Abstract] [Full Text] [Related]

  • 6. Comments on article by Dr Birkenhager et al: "Efficacy of imipramine in psychotic versus nonpsychotic depression".
    Baldessarini RJ.
    J Clin Psychopharmacol; 2008 Dec; 28(6):716; author reply 717-8. PubMed ID: 19011451
    [No Abstract] [Full Text] [Related]

  • 7. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.
    Goodwin FK, Prange AJ, Post RM, Muscettola G, Lipton MA.
    Am J Psychiatry; 1982 Jan; 139(1):34-8. PubMed ID: 7055275
    [Abstract] [Full Text] [Related]

  • 8. The timing, specificity and clinical prediction of tricyclic drug effects in depression.
    Katz MM, Koslow SH, Maas JW, Frazer A, Bowden CL, Casper R, Croughan J, Kocsis J, Redmond E.
    Psychol Med; 1987 May; 17(2):297-309. PubMed ID: 3299439
    [Abstract] [Full Text] [Related]

  • 9. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
    Möller HJ, Kasper S, Müller H, Kissling W, Fuger J, Ruhrmann S.
    Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
    [Abstract] [Full Text] [Related]

  • 10. Two-year outcome of psychotic depression in late life.
    Flint AJ, Rifat SL.
    Am J Psychiatry; 1998 Feb; 155(2):178-83. PubMed ID: 9464195
    [Abstract] [Full Text] [Related]

  • 11. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD.
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [Abstract] [Full Text] [Related]

  • 12. A double-blind comparison of bupropion and amitriptyline in depressed inpatients.
    Davidson J, Miller R, Van Wyck Fleet J, Strickland R, Manberg P, Allen S, Parrott R.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):115-7. PubMed ID: 6406438
    [Abstract] [Full Text] [Related]

  • 13. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM, Stewart JW, McGrath PJ, Tricamo E, Rabkin JG, Ocepek-Welikson K, Nunes E, Harrison W, Klein DF.
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [Abstract] [Full Text] [Related]

  • 14. Depression, Delusions, and Drug Response.
    Glassman AH, Kantor SJ, Shostak M.
    Am J Psychiatry; 1975 Jul; 132(7):716-9. PubMed ID: 1094841
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?
    Schatzberg AF, Rothschild AJ.
    Am J Psychiatry; 1992 Jun; 149(6):733-45. PubMed ID: 1590491
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.
    Maas JW, Koslow SH, Katz MM, Bowden CL, Gibbons RL, Stokes PE, Robins E, Davis JM.
    Am J Psychiatry; 1984 Oct; 141(10):1159-71. PubMed ID: 6207736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.